Tyrosine Kinases in the Regulation of Platelet Signaling: Quentin Hill Shares a PhD Opportunity
Quentin Hill, Consultant Haematologist at Leeds Teaching Hospitals NHS Trust, reposted from The Platelet Society on LinkedIn:
”And they keep coming!
Platelet biology, a fascinating topic for a PhD.”
Quoting The Platelet Society‘s post:
”PhD project opportunity!
Exciting 4-year PhD studentship available as part of the SWBio DTP PhD programme at the University of Bristol, using Proteolysis-Targeting Chimeras (PROTACs) and molecular modeling to explore how tyrosine kinases regulate platelet signaling and function.
You will gain hands-on experience in targeted protein degradation, computational modeling, and platelet biology, and will be jointly supervised by Professor Ingeborg Hers, Dr Robin Corey and Prof Varinder Aggarwal in a vibrant interdisciplinary training environment.
Project title: Targeted Protein Degradation as a Cutting-Edge Tool to Study Tyrosine Kinases in Platelet Signaling and Function (Project ID 267)
Apply by the 3rd December 2025.
Check out further details.”
Stay updated with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin